| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |